Publicación:
Factores de riesgo asociados a enfermedad renal crónica en pacientes con infección por VIH.

dc.contributor.authorCabrales Dajil, Heriberto Joséspa
dc.contributor.authorDe la Vega del Risco, Fernandospa
dc.contributor.authorCoronado Daza, Jorgespa
dc.date.accessioned2019-07-15 00:00:00
dc.date.available2019-07-15 00:00:00
dc.date.issued2019-07-15
dc.format.mimetypeapplication/pdfspa
dc.identifier.doi10.32997/rcb-2019-2874
dc.identifier.eissn2389-7252
dc.identifier.issn2215-7840
dc.identifier.urlhttps://doi.org/10.32997/rcb-2019-2874
dc.language.isospaspa
dc.publisherUniversidad de Cartagenaspa
dc.relation.bitstreamhttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/2874/2417
dc.relation.citationeditionNúm. 2 , Año 2019spa
dc.relation.citationendpage86
dc.relation.citationissue2spa
dc.relation.citationstartpage72
dc.relation.citationvolume8spa
dc.relation.ispartofjournalRevista Ciencias Biomédicasspa
dc.relation.referencesTeeraananchai S, Kerr SJ, Amin J, Ruxrungtham K, Law MG. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis. HIV medicine. 2017; 18(4): 256-66. https://doi.org/10.1111/hiv.12421spa
dc.relation.referencesJustice AC, Dombrowski E, Conigliaro J, Fultz SL, Gibson D, Madenwald T, et al. Veterans Aging Cohort Study (VACS): Overview and Description. Medical care. 2006; 44(8 Suppl 2): S13-S24. https://doi.org/10.1097/01.mlr.0000223741.02074.66spa
dc.relation.referencesWyatt CM, Winston JA, Malvestutto CD, Fishbein DA, Barash I, Cohen AJ, et al. Chronic kidney disease in HIV infection: an urban epidemic. Aids. 2007; 21(15): 2101-3. https://doi.org/10.1097/QAD.0b013e3282ef1bb4spa
dc.relation.referencesHelleberg M, May MT, Ingle SM, Dabis F, Reiss P, Fatkenheuer G, et al. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. Aids. 2015; 29(2): 221-9. https://doi.org/10.1097/QAD.0000000000000540spa
dc.relation.referencesSmit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, Sighem Av, et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. The Lancet Infectious Diseases. 2015; 15(7): 810-8. https://doi.org/10.1016/S1473-3099(15)00056-0spa
dc.relation.referencesPalella FJ, Jr., Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. Journal of acquired immune deficiency syndromes (1999). 2006; 43(1): 27-34. https://doi.org/10.1097/01.qai.0000233310.90484.16spa
dc.relation.referencesYang CH, Huang YF, Hsiao CF, Yeh YL, Liou HR, Hung CC, et al. Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005. HIV medicine. 2008; 9(7): 535-43. https://doi.org/10.1111/j.1468-1293.2008.00600.xspa
dc.relation.referencesMartinez E, Milinkovic A, Buira E, de Lazzari E, Leon A, Larrousse M, et al. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area. HIV medicine. 2007; 8(4): 251-8. https://doi.org/10.1111/j.1468-1293.2007.00468.xspa
dc.relation.referencesEhren K, Hertenstein C, Kummerle T, Vehreschild JJ, Fischer J, Gillor D, et al. Causes of death in HIV-infected patients from the Cologne-Bonn cohort. Infection. 2014; 42(1): 135-40. https://doi.org/10.1007/s15010-013-0535-7spa
dc.relation.referencesKaufman L, Collins SE, Klotman PE. The pathogenesis of HIV-associated nephropathy. Advances in chronic kidney disease. 2010; 17(1): 36-43. https://doi.org/10.1053/j.ackd.2009.08.012spa
dc.relation.referencesStokes MB, Chawla H, Brody RI, Kumar A, Gertner R, Goldfarb DS, et al. Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus. American journal of kidney diseases : the official journal of the National Kidney Foundation. 1997; 29(4): 514-25. https://doi.org/10.1016/S0272-6386(97)90332-2spa
dc.relation.referencesPeters L, Grint D, Lundgren JD, Rockstroh JK, Soriano V, Reiss P, et al. Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients. Aids. 2012; 26(15): 1917-26. https://doi.org/10.1097/QAD.0b013e3283574e71spa
dc.relation.referencesSuzuki S, Nishijima T, Kawasaki Y, Kurosawa T, Mutoh Y, Kikuchi Y, et al. Effect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1-Infected Treatment-Naive Asian Patients: Results from 12-Year Observational Cohort. AIDS patient care and STDs. 2017; 31(3): 105-12. https://doi.org/10.1089/apc.2016.0286spa
dc.relation.referencesAchhra AC, Mocroft A, Ross MJ, Ryom L, Lucas GM, Furrer H, et al. Kidney disease in antiretroviral-naive HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV medicine. 2015; 16 Suppl 1: 55-63. https://doi.org/10.1111/hiv.12234spa
dc.relation.referencesMocroft A, Kirk O, Gatell J, Reiss P, Gargalianos P, Zilmer K, et al. Chronic renal failure among HIV-1-infected patients. Aids. 2007; 21(9): 1119-27. https://doi.org/10.1097/QAD.0b013e3280f774eespa
dc.relation.referencesCrum-Cianflone N, Ganesan A, Teneza-Mora N, Riddle M, Medina S, Barahona I, et al. Prevalence and factors associated with renal dysfunction among HIV-infected patients. AIDS patient care and STDs. 2010; 24(6): 353-60. https://doi.org/10.1089/apc.2009.0326spa
dc.relation.referencesMocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, et al. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. Aids. 2010; 24(11): 1667-78. https://doi.org/10.1097/QAD.0b013e328339fe53spa
dc.relation.referencesMoso MA, Woolnough E, Langham F, Hoy JF, Cheng AC, Walker RG, et al. Increasing prevalence and risk of chronic kidney disease in HIV-positive individuals: changing demographics over a six-year period. The Journal of infectious diseases. 2017. https://doi.org/10.1093/infdis/jix676spa
dc.relation.referencesCalza L, Vanino E, Magistrelli E, Salvadori C, Cascavilla A, Colangeli V, et al. Prevalence of renal disease within an urban HIV-infected cohort in northern Italy. Clinical and Experimental Nephrology. 2014; 18(1): 104-12. https://doi.org/10.1007/s10157-013-0817-5spa
dc.relation.referencesOtero A, de Francisco A, Gayoso P, Garcia F. Prevalence of chronic renal disease in Spain: results of the EPIRCE study. Nefrología : publicación oficial de la Sociedad Española Nefrología. 2010; 30(1): 78-86.spa
dc.relation.referencesSocial MdSyP. ANALISIS DE SITUACIÓN DE SALUD (ASIS) COLOMBIA. Disponible en: https://www.minsaludgovco/sites/rid/Lists/BibliotecaDigital/RIDE/VS/ED/PSP/asis-colombia-2016pdf 2016.spa
dc.relation.referencesNishijima T, Kawasaki Y, Mutoh Y, Tomonari K, Tsukada K, Kikuchi Y, et al. Prevalence and factors associated with chronic kidney disease and end-stage renal disease in HIV-1-infected Asian patients in Tokyo. Scientific reports. 2017; 7(1): 14565. https://doi.org/10.1038/s41598-017-15214-xspa
dc.relation.referencesMallipattu SK, Salem F, Wyatt CM. The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy. Kidney Int. 2014; 86(2): 259-65. https://doi.org/10.1038/ki.2014.44spa
dc.relation.referencesIkpeme EE, Ekrikpo UE, Akpan MU, Ekaidem SI. Determining the prevalence of human immunodeficiency virus-associated nephropathy (HIVAN) using proteinuria and ultrasound findings in a Nigerian paediatric HIV population. The Pan African medical journal. 2012; 11:13.spa
dc.relation.referencesScherzer R, Estrella M, Li Y, Choi AI, Deeks SG, Grunfeld C, et al. Association of tenofovir exposure with kidney disease risk in HIV infection. Aids. 2012; 26(7): 867-75. https://doi.org/10.1097/QAD.0b013e328351f68fspa
dc.relation.referencesRho M, Perazella MA. Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients. Current drug safety. 2007; 2(2): 147-54. https://doi.org/10.2174/157488607780598269spa
dc.relation.referencesGoicoechea M, Liu S, Best B, Sun S, Jain S, Kemper C, et al. Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy. The Journal of infectious diseases. 2008; 197(1): 102-8. https://doi.org/10.1086/524061spa
dc.relation.referencesMocroft A, Lundgren JD, Ross M, Fux CA, Reiss P, Moranne O, et al. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study. The lancet HIV. 2016; 3(1): e23-32. https://doi.org/10.1016/S2352-3018(15)00211-8spa
dc.relation.referencesKalayjian RC, Lau B, Mechekano RN, Crane HM, Rodriguez B, Salata RA, et al. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care. AIDS (London, England). 2012; 26(15): 1907-15. https://doi.org/10.1097/QAD.0b013e328357f5edspa
dc.relation.referencesPerrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clinical chemistry. 1992; 38(10): 1933-53. https://doi.org/10.1093/clinchem/38.10.1933spa
dc.relation.referencesShemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985; 28(5): 830-8. https://doi.org/10.1038/ki.1985.205spa
dc.relation.referencesLevey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of internal medicine. 1999; 130(6): 461-70. https://doi.org/10.7326/0003-4819-130-6-199903160-00002spa
dc.relation.referencesLevey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Annals of internal medicine. 2009; 150(9): 604-12. https://doi.org/10.7326/0003-4819-150-9-200905050-00006spa
dc.relation.referencesLevey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clinical chemistry. 2007; 53(4): 766-72. https://doi.org/10.1373/clinchem.2006.077180spa
dc.relation.referencesVrouenraets SM, Fux CA, Wit FW, Garcia EF, Brinkman K, Hoek FJ, et al. A comparison of measured and estimated glomerular filtration rate in successfully treated HIV-patients with preserved renal function. Clinical nephrology. 2012; 77(4): 311-20. https://doi.org/10.5414/CN107214spa
dc.relation.referencesCristelli MP, Cofan F, Rico N, Trullas JC, Manzardo C, Aguero F, et al. Estimation of renal function by CKD-EPI versus MDRD in a cohort of HIV-infected patients: a cross-sectional analysis. BMC nephrology. 2017; 18(1): 58. https://doi.org/10.1186/s12882-017-0470-4spa
dc.relation.referencesGagneux-Brunon A, Botelho-Nevers E, Delanaye P, Lucht F, Fresard A, Cazorla C, et al. CKD-EPI equation: A suitable Glomerular Filtration Rate estimate for drug dosing in HIV-infected patients. Medecine et maladies infectieuses. 2017. https://doi.org/10.1016/j.medmal.2017.04.001spa
dc.relation.referencesOkparavero AA, Tighiouart H, Krishnasami Z, Wyatt CM, Graham H, Hellinger J, et al. Use of glomerular filtration rate estimating equations for drug dosing in HIV-positive patients. Antiviral therapy. 2013; 18(6): 793-802. https://doi.org/10.3851/IMP2676spa
dc.relation.referencesLucas GM, Ross MJ, Stock PG, Shlipak MG, Wyatt CM, Gupta SK, et al. Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2014; 59(9): e96-e138. https://doi.org/10.1093/cid/ciu617spa
dc.relation.referencesAndrassy KM. Comments on 'KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease'. Kidney Int. 2013; 84(3): 622-3. https://doi.org/10.1038/ki.2013.243spa
dc.relation.referencesStevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Annals of internal medicine. 2013; 158(11): 825-30. https://doi.org/10.7326/0003-4819-158-11-201306040-00007spa
dc.relation.referencesInker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2014; 63(5): 713-35. https://doi.org/10.1053/j.ajkd.2014.01.416spa
dc.relation.referencesChobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Jama. 2003; 289(19): 2560-72. https://doi.org/10.1001/jama.289.19.2560spa
dc.relation.references2. Classification and Diagnosis of Diabetes. Diabetes care. 2017; 40(Suppl 1): S11-s24. https://doi.org/10.2337/dc17-S005spa
dc.relation.referencesDiaz K. PREVALENCIA DE ALTERACIÓN RENAL EN UNA POBLACIÓN AMBULATORIA CON VIH-SIDA DE CARTAGENA (TRABAJO DE GRADO). Universidad de Cartagena, Bolívar, Colombia. 2009.spa
dc.relation.referencesCosto FCdEdA. Situación de la Enfermedad Renal Crónica, la hipertensión arterial y la diabetes mellitus en Colombia 2016. Cuenta de Alto Costo. 2017: 57,107.spa
dc.relation.referencesLamb EJ, O'Riordan SE, Delaney MP. Kidney function in older people: pathology, assessment and management. Clin Chim Acta. 2003; 334(1-2): 25-40. https://doi.org/10.1016/S0009-8981(03)00246-8spa
dc.relation.referencesLucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD. Chronic Kidney Disease Incidence, and Progression to End-Stage Renal Disease, in HIV-Infected Individuals: A Tale of Two Races. The Journal of infectious diseases. 2008; 197(11): 1548-57. https://doi.org/10.1086/587994spa
dc.relation.referencesOverton ET, Nurutdinova D, Freeman J, Seyfried W, Mondy KE. Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy. HIV medicine. 2009; 10(6): 343-50. https://doi.org/10.1111/j.1468-1293.2009.00693.xspa
dc.relation.referencesFernando SK, Finkelstein FO, Moore BA, Weissman S. Prevalence of chronic kidney disease in an urban HIV infected population. The American journal of the medical sciences. 2008; 335(2): 89-94. https://doi.org/10.1097/MAJ.0b013e31812e6b34spa
dc.relation.referencesCoresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. Jama. 2007; 298(17): 2038-47. https://doi.org/10.1001/jama.298.17.2038spa
dc.relation.referencesGrams ME, Juraschek SP, Selvin E, Foster MC, Inker LA, Eckfeldt JH, et al. Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2013; 62(2): 253-60. https://doi.org/10.1053/j.ajkd.2013.03.013spa
dc.relation.referencesChapter 2: Definition, identification, and prediction of CKD progression. Kidney International Supplements. 2013; 3(1): 63-72. https://doi.org/10.1038/kisup.2012.65spa
dc.relation.referencesWinocour PH. Diabetes and chronic kidney disease: an increasingly common multi-morbid disease in need of a paradigm shift in care. Diabetic medicine : a journal of the British Diabetic Association. 2017. https://doi.org/10.1111/dme.13564spa
dc.relation.referencesMedapalli R, Parikh CR, Gordon K, Brown ST, Butt AA, Gibert CL, et al. Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: Data from the Veterans Aging Cohort Study. Journal of acquired immune deficiency syndromes (1999). 2012; 60(4): 393-9. https://doi.org/10.1097/QAI.0b013e31825b70d9spa
dc.relation.referencesSquires K, Pozniak AL, Pierone G, Jr., Steinhart CR, Berger D, Bellos NC, et al. Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trial. Annals of internal medicine. 2003; 139(5 Pt 1): 313-20. https://doi.org/10.7326/0003-4819-139-5_Part_1-200309020-00006spa
dc.relation.referencesJones R, Stebbing J, Nelson M, Moyle G, Bower M, Mandalia S, et al. Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control study. Journal of acquired immune deficiency syndromes (1999). 2004; 37(4): 1489-95. https://doi.org/10.1097/01.qai.0000138983.45235.02spa
dc.relation.referencesKooij KW, Vogt L, Wit F, van der Valk M, van Zoest RA, Goorhuis A, et al. Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls. The Journal of infectious diseases. 2017; 216(6): 622-31. https://doi.org/10.1093/infdis/jix202spa
dc.relation.referencesSocial MdSyP. Guía para el Manejo del VIH/SIDA - Basada en la Evidencia - COLOMBIA. 2014.spa
dc.relation.referencesKalayjian RC, Lau B, Mechekano RN, Crane HM, Rodríguez B, Salata RA, et al. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care. Aids. 2012; 26(15): 1907-15. https://doi.org/10.1097/QAD.0b013e328357f5edspa
dc.rightsRevista Ciencias Biomédicas - 2019spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.creativecommonsEsta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/2874spa
dc.subjectEnfermedad renal crónicaspa
dc.subjectVIHspa
dc.subjectNefrotoxicidadspa
dc.subjectChronic kidney insufficiencyeng
dc.subjectHIVeng
dc.subjectNephrotoxicityeng
dc.titleFactores de riesgo asociados a enfermedad renal crónica en pacientes con infección por VIH.spa
dc.title.translatedRisk factors associated with chronic kidney disease in patients with HIV infection.eng
dc.typeArtículo de revistaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.localJournal articleeng
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublication

Archivos

Datos de Contacto

Imagen Escudo Universidad de Cartagena

 

 

 

Línea de Atención

Línea Anticorrupción

Síguenos en: